Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 3c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q3 EPS of ($0.37), $0.03 better than the analyst estimate of ($0.40) .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• United Community Banks completes $2B Navitas sale to Wafra
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue